Form 8-K - Current report:
SEC Accession No. 0001511164-17-000352
Filing Date
2017-06-19
Accepted
2017-06-19 14:50:01
Documents
1
Period of Report
2017-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 document1.htm 8-K 15315
  Complete submission text file 0001511164-17-000352.txt   16606
Mailing Address 1361 PELTIER DR. POINT ROBERTS WA 98281
Business Address 1361 PELTIER DR. POINT ROBERTS WA 98281 (604) 783-9664
Lotus Biotech Development Corp. (Filer) CIK: 0001520592 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54745 | Film No.: 17918279
SIC: 7812 Services-Motion Picture & Video Tape Production